- Published at
- by manilatimes.net
mixed
mixed
News for aTyr Pharma, Inc. (LIFE)
- Published at
- by seekingalpha.com
mixedmixedaTyr Pharma, Inc. (ATYR) Q4 2024 Earnings Call Transcript
aTyr Pharma, Inc. (NASDAQ:ATYR) Q4 2024 Earnings Conference Call March 13, 2025 5:00 PM ETCompany ParticipantsAshlee Dunston - Senior Director of Investor...- Published at
- by gurufocus.com
mixedmixedaTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
Topline data from Phase 3 EFZO-FITâ„¢ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzo- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveaTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. ( ATYR), a clinical stage biotechnology company engaged in the discovery and development of fir- Published at
- by benzinga.com
positivepositiveThis aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - enGene Holdings (NASDAQ:ENGN), aTyr Pharma (NASDAQ:ATYR)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...- Published at
- by seekingalpha.com
positivepositiveaTyr Pharma: Interesting Drug, Difficult Target Market (ATYR)
aTyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors cautious. See why ATYR stock is a Hold.- Published at
- by benzinga.com
mixedmixedThis Toast Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - aTyr Pharma (NASDAQ:ATYR), Nano X Imaging (NASDAQ:NNOX)
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiation...- Published at
- by gurufocus.com
positivepositiveaTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. ( ATYR) (”aTyr” or the ”Company”), a clinical stage biotechnology company engaged in th- Published at
- by gurufocus.com
positivepositiveaTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
ATYR0101 interacts with LTBP-1 to induce myofibroblast apoptosis through a novel anti-fibrotic mechanism to reduce fibrosis and fibrotic markers in models of l- Published at
- by insidermonkey.com
positivepositiveIs aTyr Pharma, Inc. (ATYR) the Best Multibagger Stock to Buy Heading into 2025?
We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a look at where aTyr Pharma, Inc.- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
neutralneutralaTyr Pharma Inc Reports Q3 Revenue of $0.353 Million, GAAP EPS Loss of $0.23, Beating Analyst Estimates
Revenue: Reported $0.353 million for the third quarter, significantly surpassing the analyst estimate of $0.02 million.Net Loss: Recorded a net loss of $17.26- Published at
- by seekingalpha.com
positivepositiveaTyr Pharma: The Bull Has Finally Come Out (NASDAQ:ATYR)
aTyr Pharma has a pivotal year ahead with key readouts for Efzofitimod, potentially opening a huge market. Find out why ATYR stock is a Buy.- Published at
- by investing.com
positivepositiveaTyr Pharma maintains $22 target on trial data optimism By Investing.com
aTyr Pharma maintains $22 target on trial data optimism- Published at
- by rttnews.com
mixedmixedPre-market Movers: BENF, SAVE, CETX, PW, AVGR…
Texas-based Beneficient (BENF), a technology-enabled financial services company is up over 55 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.- Published at
- by globenewswire.com
mixedmixedJasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused...- Published at
- by gurufocus.com
positivepositiveWAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months
WAVE Life Sciences Ltd. (WVE), a preclinical biopharmaceutical company, has seen a significant increase in its stock price over the past three months. The compa- Published at
- by globenewswire.com
neutralneutralAmyotrophic Lateral Sclerosis Market to Surge Immensely by 2032, Predicts DelveInsight | Key Companies to Watch Out - Cytokinetics, Orphazyme, Orion, Biogen, AB Science, Ionis, Biohaven, MediciNova, N
The dynamics of the amyotrophic lateral sclerosis market are anticipated to change in the coming years owing to the improvement in the diagnosis...- Published at
- by investorideas.com
mixedmixedNew Stocks and Trading Ideas (Nasdaq: LIFE) (Nasdaq: LSTA) (TSXV: CDX) (Nasdaq: REUN) (CSE: LIM) (TSXV: FUSE)
Vancouver, Kelowna, Delta, BC - February 10, 2023 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces ...